Fighting disease with tiny, targeted, crystalline drug mules
Development of effective new treatments for cancer, dementia, Parkinson's disease and other brain conditions is becoming possible from breakthrough discoveries being made in nanotechnology.
Research co-led by Eureka Prize winner Professor Dayong Jin at UTS, in collaboration with colleagues at Macquarie University, the University of Wollongong and the National University of Singapore, has taken a huge step closer to the engineering of nanoscale devices to aid the delivery of life-saving drug treatments.
A renowned biophotonics scientist, Professor Jin said such minute devices have the potential to be engineered to efficiently and more safely deliver drug treatments directly to the location of diseased cells while helping avoid harm to healthy cells that fall victim to toxic drugs administered by conventional means.
"Treatment for aggressive cancers by with radiation or chemical drugs might kill cancer cells, but can also kill up to 70 to 90 per cent of healthy cells," Professor Jin said.
Read the full story in the UTS Newsroom.
